Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study

被引:115
|
作者
Trottier, Jocelyn [1 ,2 ]
Bialek, Andrzej [3 ]
Caron, Patrick [1 ,2 ]
Straka, Robert J. [4 ]
Heathcote, Jenny [5 ]
Milkiewicz, Piotr [6 ,7 ]
Barbier, Olivier [1 ,2 ]
机构
[1] CHUQ Res Ctr, Mol Pharmacol Lab, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[3] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland
[4] Univ Minnesota, Coll Pharm, Expt & Clin Pharmacol Dept, Minneapolis, MN 55455 USA
[5] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada
[6] Pomeranian Med Univ, Liver Unit, Szczecin, Poland
[7] Pomeranian Med Univ, Liver Res Labs, Szczecin, Poland
关键词
Cholestasis; LC-MS/MS; Primary biliary cirrhosis; Primary sclerosing cholangitis; Plasma bile acids; CHOLESTATIC LIVER-DISEASE; TANDEM MASS-SPECTROMETRY; INTRAHEPATIC CHOLESTASIS; CLINICAL-FEATURES; HUMAN HEPATOCYTES; FENOFIBRATE; TOXICITY; PLASMA; GOLDN; HEPATOTOXICITY;
D O I
10.1016/j.dld.2011.10.025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Primary biliary cirrhosis and primary sclerosing cholangitis are two cholestatic diseases characterised by hepatic accumulation of bile acids. Aims: This study compares serum bile acid levels in patients with primary biliary cirrhosis and primary sclerosing cholangitis and from age and sex-matched non cholestatic donors. Methods: Seventeen bile acids were quantified using liquid chromatography coupled to tandem mass spectrometry. Serum samples from cholestatic patients were compared with those of non-cholestatic donors. Results: The concentration of total bile acids, taurine and glycine conjugates of primary bile acids was elevated in both patients with primary biliary cirrhosis and primary sclerosing cholangitis when compared to non-cholestatic donors. Samples from primary sclerosing cholangitis patients displayed reduced levels of secondary acids, when compared to non cholestatic and primary biliary cirrhosis sera. The ratio of total glycine versus total taurine conjugates was reduced in patients with primary biliary cirrhosis, but not in primary sclerosing cholangitis. Conclusion: The present study suggests that circulating bile acids are altered differentially in primary biliary cirrhosis and primary sclerosing cholangitis patients. (C) 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:303 / 310
页数:8
相关论文
共 50 条
  • [1] Metabolomic Profiling of Portal Blood and Bile in Patients with Primary Sclerosing Cholangitis
    O'Hara, Steven P.
    Bogert, Pamela S. Tietz
    Nandakumar, Madhu
    Halvorsen, Elizabeth
    Tabibian, James H.
    Cheung, Angela
    LaRusso, Nicholas F.
    [J]. HEPATOLOGY, 2018, 68 : 1126A - 1126A
  • [2] Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis
    Mindikoglu, Ayse L.
    Coarfa, Cristian
    Opekun, Antone R.
    Shah, Vijay H.
    Arab, Juan P.
    Lazaridis, Konstantinos N.
    Putluri, Nagireddy
    Ambati, Chandrashekar R.
    Robertson, Matthew J.
    Devaraj, Sridevi
    Jalal, Prasun K.
    Rana, Abbas
    Goss, John A.
    Dowling, Thomas C.
    Weir, Matthew R.
    Seliger, Stephen L.
    Raufman, Jean-Pierre
    Bernard, David W.
    Vierling, John M.
    [J]. FUTURE SCIENCE OA, 2020, 6 (02):
  • [3] DIFFERENCES IN CHANGES OF INDIVIDUAL SERUM BILE-ACIDS BETWEEN PRIMARY SCLEROSING CHOLANGITIS AND PRIMARY BILIARY-CIRRHOSIS
    ISHII, K
    ODA, M
    AZUMA, T
    NISHIZAKI, Y
    YOKOMORI, H
    NISHIDA, J
    INOUE, J
    WATANABE, N
    TSUCHIYA, M
    [J]. HEPATOLOGY, 1990, 12 (02) : 414 - 414
  • [4] Primary biliary cirrhosis and primary sclerosing cholangitis
    Stiehl, A
    [J]. NEW TRENDS IN HEPATOLOGY 1996, 1997, 92 : 84 - 90
  • [5] Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis
    Bell, Lauren N.
    Wulff, Jacob
    Comerford, Megan
    Vuppalanchi, Raj
    Chalasani, Naga
    [J]. LIVER INTERNATIONAL, 2015, 35 (01) : 263 - 274
  • [6] Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis
    van Os, Erik
    van den Broek, Walter W.
    Mulder, Paul G. H.
    ter Borg, Pieter C. J.
    Bruijn, Jan A.
    van Buuren, Henk R.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 (06) : 1099 - 1103
  • [7] Hydroxylysylpyridinoline in bile - A new marker for primary sclerosing cholangitis and primary biliary cirrhosis?
    Gillessen, A
    Acil, Y
    Brinckmann, J
    Muller, PK
    Domschke, W
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A455 - A455
  • [8] Immunology of primary biliary cirrhosis and primary sclerosing cholangitis
    Lleo, A.
    Selmi, C.
    Invernizzi, P.
    Podda, M.
    Gershwin, M. E.
    [J]. PATHOGENESIS AND CLINICAL PRACTICE IN GASTROENTEROLOGY, 2008, 160 : 191 - 207
  • [9] Update on primary biliary cirrhosis and primary sclerosing cholangitis
    Jia, Ji-Dong
    Duan, Wei-Jia
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 57 - 57
  • [10] Recognizing primary biliary cirrhosis and primary sclerosing cholangitis
    Buckley, SE
    DiPalma, JA
    [J]. AMERICAN FAMILY PHYSICIAN, 1996, 53 (01) : 195 - 200